GLP-1 Receptor Agonist Use and Clinical Outcomes in Patients With Hidradenitis Suppurativa

JAMA Dermatology · Published 2026-07-01 · DOI 10.1001/jamadermatol.2026.1907

Free full text

Authors (3)

Beata Jastrząb-Miśkiewicz, Jacek C. Szepietowski, Piotr K. Krajewski

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Jastrząb-Miśkiewicz, B., Szepietowski, J., Krajewski, P. (2026). GLP-1 Receptor Agonist Use and Clinical Outcomes in Patients With Hidradenitis Suppurativa. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2026.1907

Related articles

• JAMA+ Trials Editor’s Choice for Clinical Trial of 2025 in JAMA Dermatology · JAMA Dermatology · 2026 · Same journal
• Dyschromatosis and Blistering in a Young Male · JAMA Dermatology · 2026 · Same journal
• JAMA Dermatology · JAMA Dermatology · 2026 · Same journal
• Progression From Acute to Chronic Urticaria · JAMA Dermatology · 2026 · Same journal
• Characterizing Dermoscopic Features of Longitudinal Melanonychia in Skin of Color · JAMA Dermatology · 2026 · Same journal
• Melasma · JAMA Dermatology · 2026 · Same journal
• Error in Title · JAMA Dermatology · 2026 · Same journal
• Early Respiratory Infection Burden and Atopic Dermatitis in Childhood · JAMA Dermatology · 2026 · Same journal
• Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa · JAMA Dermatology · 2026 · Same journal
• Commercial Price Variation for Common Dermatologic Procedures · JAMA Dermatology · 2026 · Same journal